Cargando…

Human papillomavirus testing as a primary screening tool for cervical cancer

Detalles Bibliográficos
Autores principales:	Cho, Hyun-Woong, Hong, Jin Hwa, Lee, Jae Kwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039169/ https://www.ncbi.nlm.nih.gov/pubmed/33825364 http://dx.doi.org/10.3802/jgo.2021.32.e56

Ejemplares similares

Human papillomavirus testing in cervical cancer screening
por: Franceschi, S, et al.
Publicado: (2005)

Accuracy of human papillomavirus tests on self-collected urine versus clinician-collected samples for the detection of cervical precancer: a systematic review and meta-analysis
por: Cho, Hyun-Woong, et al.
Publicado: (2021)

Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014–2016
por: Ouh, Yung-Taek, et al.
Publicado: (2018)

Type-specific persistence or regression of human papillomavirus genotypes in women with cervical intraepithelial neoplasia 1: A prospective cohort study
por: Cho, Hyun Woong, et al.
Publicado: (2015)

Utility of Human Papillomavirus Testing for Cervical Cancer Screening in Korea
por: Kim, Mee-seon, et al.
Publicado: (2020)

Quality assurance in human papillomavirus testing for primary cervical screening
por: Cuschieri, Kate, et al.
Publicado: (2023)

Validation of the cobas 6800 human papillomavirus test in primary cervical screening
por: Sundström, Karin, et al.
Publicado: (2021)

Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway
por: Burger, E A, et al.
Publicado: (2012)

Performance and Diagnostic Accuracy of Human Papillomavirus Testing on Self-Collected Urine and Vaginal Samples in a Referral Population
por: Cho, Hyun-Woong, et al.
Publicado: (2021)

Risk factors for type-specific persistence of high-risk human papillomavirus and residual/recurrent cervical intraepithelial neoplasia after surgical treatment
por: Ouh, Yung-Taek, et al.
Publicado: (2020)

Primary cervical screening with high risk human papillomavirus testing: observational study
por: Rebolj, Matejka, et al.
Publicado: (2019)

Tumor human papillomavirus: a potential test for cervical cancer prognosis
por: Le, Tan Minh, et al.
Publicado: (2023)

The role of human papillomavirus testing after treatment for high-grade cervical dysplasia
por: Turner, Taylor B, et al.
Publicado: (2016)

Comparison of papanicolaou smear and human papillomavirus (HPV) test as cervical screening tools: can we rely on HPV test alone as a screening method? An 11-year retrospective experience at a single institution
por: Kang, Myunghee, et al.
Publicado: (2020)

Updates of the current screening guidelines for the early detection of cervical cancer
por: Hong, Jin Hwa, et al.
Publicado: (2013)

By how much could screening by primary human papillomavirus testing reduce cervical cancer incidence in England?
por: Castanon, Alejandra, et al.
Publicado: (2016)

Overview of organisational methods of primary cervical lesion screening programmes that use human papillomavirus testing
por: Marchadier, Agathe, et al.
Publicado: (2023)

Comparison of the Novel Human Papillomavirus 4 Auto-capillary Electrophoresis Test with the Hybrid Capture 2 Assay and with the PCR HPV Typing Set Test in the Detection of High-Risk HPV Including HPV 16 and 18 Genotypes in Cervical Specimens
por: Hong, Jin Hwa, et al.
Publicado: (2009)

Extension of cervical screening intervals with primary human papillomavirus testing: observational study of English screening pilot data
por: Rebolj, Matejka, et al.
Publicado: (2022)

Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer
por: Jin, Yingji, et al.
Publicado: (2018)

Cervical Cancer Screening after Perimenopause: How Is Human Papillomavirus Test Performed?
por: Chung, Soo-Ho
Publicado: (2016)

Evaluation of human-papillomavirus testing and visual inspection for cervical cancer screening in Rwanda
por: Umulisa, M. Chantal, et al.
Publicado: (2018)

Cytology and High-Risk Human Papillomavirus Test for Cervical Cancer Screening Assessment
por: Stuebs, Frederik A., et al.
Publicado: (2022)

Cost‐effectiveness analysis of primary human papillomavirus testing in cervical cancer screening: Results from the HPV FOCAL Trial
por: Cromwell, Ian, et al.
Publicado: (2021)

Human papillomavirus testing in primary cervical screening and the cut-off level for hybrid capture 2 tests: systematic review
por: Rebolj, Matejka, et al.
Publicado: (2011)

High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology
por: Kong, Tae-Wook, et al.
Publicado: (2020)

High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology
por: Kong, Tae-Wook, et al.
Publicado: (2019)

Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing
por: van Rosmalen, J, et al.
Publicado: (2012)

Awareness and Support of Clinician- and Patient-Collected Human Papillomavirus Testing for Cervical Cancer Screening Among Primary Care Clinicians
por: MacLaughlin, Kathy L., et al.
Publicado: (2022)

Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women
por: Clavel, C, et al.
Publicado: (2001)

The prevalence and role of human papillomavirus genotypes in primary cervical screening in the northeast of China
por: Wang, Shizhuo, et al.
Publicado: (2012)

Human Papillomavirus Prevalence and Type Distribution Among 968 Women in South Korea
por: So, Kyeong A, et al.
Publicado: (2016)

Xpert human papillomavirus test is a promising cervical cancer screening test for HIV-seropositive women
por: Mbulawa, Zizipho Z.A., et al.
Publicado: (2016)

Human Papillomavirus Cervical Infection: Many Ways to a Single Destination
por: Gardella, Barbara, et al.
Publicado: (2022)

Human papillomavirus genotyping as a tool for cervical cancer prevention: from commercially available human papillomavirus DNA test to next-generation sequencing
por: Dias, Tauana Christina, et al.
Publicado: (2020)

Prevent cervical cancer by screening with reliable human papillomavirus detection and genotyping
por: Ge, Shichao, et al.
Publicado: (2012)

Effectiveness and feasibility of self-sampling for human papillomavirus testing for internet-based cervical cancer screening
por: Li, Jingran, et al.
Publicado: (2022)

Self-Sampling for Human Papillomavirus Testing: Increased Cervical Cancer Screening Participation and Incorporation in International Screening Programs
por: Gupta, Sarah, et al.
Publicado: (2018)

Triage human papillomavirus testing for cytology-based cervical screening in women of different ages in primary hospitals: A retrospective clinical study
por: Zhang, Yuan-yuan, et al.
Publicado: (2020)

Human Papillomavirus Testing in the Last Cervical Screening Round at Age 60–64 Years
por: Schroll, Jeppe Bennekou, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gd20t7528eoi1vli7c33guiou0